Minagawa T, Kohno Y, Suwa T, Tsuji A
Research Center, Taisho Pharmaceutical Co. Ltd, Ohmiya, Japan.
Biochem Pharmacol. 1995 May 17;49(10):1361-5. doi: 10.1016/0006-2952(95)00071-7.
Species differences in the hydrolysis of isocarbacyclin methyl ester (TEI-9090) in whole blood and in its separated components were studied in rats, dogs and human. Esterase activity in rat whole blood was approximately 100 and 400 times higher than that in dog and human whole blood, respectively, and was attributed to high plasma activity. In contrast, TEI-9090 hydrolysis activities in dog and human blood were due to red blood cells (RBC), whose activity in humans was slightly suppressed by albumin. In dogs, activity in RBC membranes was 10 times greater than in the cytosol, while in human membrane and cytosol activity was virtually the same. The effects of the esterase inhibitor diisopropylfluorophosphate, bis-p-nitrophenylphosphate (BNPP), eserine, 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) and p-chloromercuribenzoate showed that the rat plasma and RBC cytosol esterases hydrolysing TEI-9090 were carboxylesterase (CarbE) and arylesterase (ArE), respectively. The esterases in dog plasma and RBC membrane were CarbE, and RBC cytosol esterase was ArE. In humans, the esterase activities in plasma, RBC membrane and cytosol were butyrylcholinesterase, CarbE and ArE, respectively.
在大鼠、狗和人类中研究了异卡前列甲酯(TEI-9090)在全血及其分离成分中的水解种属差异。大鼠全血中的酯酶活性分别比狗和人类全血中的酯酶活性高约100倍和400倍,这归因于血浆中的高活性。相比之下,狗和人类血液中TEI-9090的水解活性归因于红细胞(RBC),白蛋白对人类红细胞的活性有轻微抑制作用。在狗中,红细胞膜中的活性比胞质溶胶中的活性高10倍,而在人类中,膜和胞质溶胶中的活性几乎相同。酯酶抑制剂二异丙基氟磷酸酯、双对硝基苯基磷酸酯(BNPP)、毒扁豆碱、5,5'-二硫代双(2-硝基苯甲酸)(DTNB)和对氯汞苯甲酸的作用表明,水解TEI-9090的大鼠血浆和红细胞胞质溶胶酯酶分别是羧酸酯酶(CarbE)和芳香酯酶(ArE)。狗血浆和红细胞膜中的酯酶是CarbE,红细胞胞质溶胶酯酶是ArE。在人类中,血浆、红细胞膜和胞质溶胶中的酯酶活性分别是丁酰胆碱酯酶、CarbE和ArE。